While the exact contribution of NAAD+ to the pathology of NADSYN1 deficiency remains unknown, NAAD+ could potentially be used as a new diagnostic marker. This evidence concerns the gene NADSYN1 and hyperinsulinemic hypoglycemia, familial, 4.